943 related articles for article (PubMed ID: 18040529)
1. The effect of tiotropium on the pulmonary diffusing capacity.
Gonlugur U
Methods Find Exp Clin Pharmacol; 2007 Oct; 29(8):535-7. PubMed ID: 18040529
[TBL] [Abstract][Full Text] [Related]
2. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
[TBL] [Abstract][Full Text] [Related]
3. Tiotropium administered by a pressurized metered dose inhaler (pMDI) and spacer produces a similar bronchodilator response as that administered by a Rotahaler in adult subjects with stable moderate-to-severe COPD.
Brashier B; Dhembare P; Jantikar A; Mahadik P; Gokhale P; Gogtay JA; Salvi SS
Respir Med; 2007 Dec; 101(12):2464-71. PubMed ID: 17719763
[TBL] [Abstract][Full Text] [Related]
4. A prospective study of pulmonary function in patients treated with paclitaxel and carboplatin.
Dimopoulou I; Galani H; Dafni U; Samakovii A; Roussos C; Dimopoulos MA
Cancer; 2002 Jan; 94(2):452-8. PubMed ID: 11900231
[TBL] [Abstract][Full Text] [Related]
5. Melatonin administration acutely decreases the diffusing capacity of carbon monoxide in human lungs.
Vardar SA; Altun GD; Günerbuyuk C; Hatipoglu ON; Mert S; Kaymak K
Respiration; 2006; 73(4):509-13. PubMed ID: 16195665
[TBL] [Abstract][Full Text] [Related]
6. [Efficacy of tiotropium bromide (Spiriva) in patients with chronic-obstructive pulmonary disease (COPD) of different severities].
Beeh KM; Beier J; Buhl R; Stark-Lorenzen P; Gerken F; Metzdorf N;
Pneumologie; 2006 Jun; 60(6):341-6. PubMed ID: 16761228
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary function in symptom-free asthmatics.
Yaacob I; Mohammad M
Singapore Med J; 1993 Dec; 34(6):522-3. PubMed ID: 8153715
[TBL] [Abstract][Full Text] [Related]
8. Diurnal variation in pulmonary diffusing capacity and expiratory volumes.
Panda A; McHardy G
Indian J Physiol Pharmacol; 1980; 24(2):112-8. PubMed ID: 7189745
[TBL] [Abstract][Full Text] [Related]
9. Importance of adjusting carbon monoxide diffusing capacity (DLCO) and carbon monoxide transfer coefficient (KCO) for alveolar volume.
Johnson DC
Respir Med; 2000 Jan; 94(1):28-37. PubMed ID: 10714476
[TBL] [Abstract][Full Text] [Related]
10. Different diffusing capacity of the lung for carbon monoxide as predictors of respiratory morbidity.
Cerfolio RJ; Bryant AS
Ann Thorac Surg; 2009 Aug; 88(2):405-10; discussion 410-1. PubMed ID: 19632384
[TBL] [Abstract][Full Text] [Related]
11. Physiologic definitions of obliterative bronchiolitis in heart-lung and double lung transplantation: a comparison of the forced expiratory flow between 25% and 75% of the forced vital capacity and forced expiratory volume in one second.
Patterson GM; Wilson S; Whang JL; Harvey J; Agacki K; Patel H; Theodore J
J Heart Lung Transplant; 1996 Feb; 15(2):175-81. PubMed ID: 8672521
[TBL] [Abstract][Full Text] [Related]
12. Acute bronchodilator responsiveness to tiotropium in postinfectious bronchiolitis obliterans in children.
Teixeira MFC; Rodrigues JC; Leone C; Adde FV
Chest; 2013 Sep; 144(3):974-980. PubMed ID: 23558666
[TBL] [Abstract][Full Text] [Related]
13. Effect of salbutamol on the measurement of single-breath diffusing capacity.
Yang J; Stanton J; Wang L; Beckert L; Frampton C; Burton D; Swanney MP
Respirology; 2013 Nov; 18(8):1223-9. PubMed ID: 23701193
[TBL] [Abstract][Full Text] [Related]
14. DLCO versus DLCO/VA as predictors of pulmonary gas exchange.
Kaminsky DA; Whitman T; Callas PW
Respir Med; 2007 May; 101(5):989-94. PubMed ID: 17055236
[TBL] [Abstract][Full Text] [Related]
15. Effects on diffusing capacity and ventilation--perfusion relationships of budesonide inhalations for 2 months in chronic obstructive pulmonary disease (COPD).
Sandek K; Bratel T; Lagerstrand L
Respir Med; 2001 Aug; 95(8):676-84. PubMed ID: 11530957
[TBL] [Abstract][Full Text] [Related]
16. Tiotropium and salmeterol/fluticasone combination do not cause oxygen desaturation in COPD.
Andò F; Ruggeri P; Girbino G; Cazzola M
Respir Med; 2008 Jun; 102(6):815-8. PubMed ID: 18343646
[TBL] [Abstract][Full Text] [Related]
17. Pulmonary function in children treated for rhabdomyosarcoma.
Kaplan E; Sklar C; Wilmott R; Michaels S; Ghavimi F
Med Pediatr Oncol; 1996 Aug; 27(2):79-84. PubMed ID: 8649324
[TBL] [Abstract][Full Text] [Related]
18. [Effects of oxitropium bromide on exercise and lung function in patients with pulmonary emphysema].
Nakanishi N; Ueda N; Kitade M; Moritaka T; Kamei T
Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Jan; 35(1):38-42. PubMed ID: 9071154
[TBL] [Abstract][Full Text] [Related]
19. [Changes in pulmonary function in SARS patients during the three-year convalescent period].
Liu YX; Ye YP; Zhang P; Chen J; Ye H; He YH; Li N
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Sep; 19(9):536-8. PubMed ID: 17767822
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary dysanapsis and diving assessments.
Ong LM; Bennett MH; Thomas PS
Undersea Hyperb Med; 2009; 36(5):375-80. PubMed ID: 20112528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
